Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
National Alliance for Sickle Cell Centers · with Beam Therapeutics Inc. · NCT06071377
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1000
- US sites recruiting
- 8
- Study start
- April 1, 2023
- Record last updated
- October 7, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences in those with varying quantities of HbS and assess for potential clinical complications of SCT.
Being studied: Biologic Specimen Collection
Conditions: Sickle Cell Trait
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Are willing to voluntarily participate and sign the study consent
- Know/suspect they have SCT and are willing to get tested to confirm/learn about their SCT status
- Adults ages 18 and older
Exclusion Criteria
- Unwilling to sign consent
- Known end-stage renal disease or dialysis
- Known SCD (including sickle cell-beta thalassemia)
- People who do not have SCT
Recruiting US locations
University of Alabama
Birmingham, AL 35294
Site contact: Marteesa William Oliver · marteesawilliams@uabmc.edu
Nemours Children's Hospital
Wilmington, DE 19803
Site contact: Nicole Wittmeyer · Nicole.Wittmeyer@nemours.org
Indiana University
Indianapolis, IN 46202
Site contact: Claire Kendrick · cjkendri@iu.edu
Functional Fluidics
Detroit, MI 48202
Site contact: Jennell White, PhD · jennell.white@functionalfluidics.com
University of North Carolina
Chapel Hill, NC 27599
Site contact: David Wichlan · david_wichlan@med.unc.edu
Duke University
Durham, NC 27710
Site contact: Morgan Low · morgan.low@duke.edu
East Carolina University
Greenville, NC 27834
Site contact: Chloe Wilde · wildec26@ecu.edu
UT Health Houston
Houston, TX 77030
Site contact: Amanda Gregg · amanda.gregg@uth.tmc.edu
Study contacts (from the official record)
- Julie Kanter, MD · (202) 596-1548 · jkanter@sicklecellcenters.org
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65